Asthma in pregnancy

doi:10.5497/wjp.v3.i4.56

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

(436)

(366)

(0)

(13572)

(2)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Pharmacol. Dec 9, 2014; 3(4): 56-71
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.56

Table 2 Stepwise approach to asthma therapy in pregnant and nonpregnant patients[49,60,62]

	Step	Preferred therapy in nonpregnant patients	Preferred therapy in pregnant patients	Alternative therapy in pregnant patients
Intermittent asthma	1	SABA, as needed¹	SABA, as needed¹	N/A
Persistent asthma	2	Low-dose ICS	Low-dose ICS	LTRA
	3	Low-dose ICS + LABA, or medium-dose ICS	Medium-dose ICS	LTRA
	4	Medium-dose ICS +LABA	Low-dose ICS + LABA	Medium-dose ICS, or
				high-dose ICS, or
				low-dose ICS + LABA + LTRA
	5	High-dose ICS + LABA	Medium-dose ICS +LABA, or high-dose ICS + LABA	LTRA + theophylline
	6	High-dose ICS + LABA + oral corticosteroid	High-dose ICS + LABA + oral corticosteroids	Omalizumab

¹SABA should be included as quick-acting rescue medication to be used as needed in all patients. SABA: Short-acting beta-agonist; LABA: Long-acting beta-agonist; ICS: Inhaled corticosteroid.

Full Size Table

Citation: Blackburn HK, Allington DR, Procacci KA, Rivey MP. Asthma in pregnancy. World J Pharmacol 2014; 3(4): 56-71
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/56.htm
DOI: https://dx.doi.org/10.5497/wjp.v3.i4.56

Blackburn HK, Allington DR, Procacci KA, Rivey MP. Asthma in pregnancy. World J Pharmacol 2014; 3(4): 56-71 [DOI: 10.5497/wjp.v3.i4.56]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.